Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NetraMark is a generative AI company that provides advanced data analytics and machine learning solutions to the pharmaceutical and biotechnology industries. The company's proprietary NetraAI platform is designed to identify hidden patient subpopulations and explain the biological mechanisms driving clinical trial outcomes. By transforming complex data into actionable insights, NetraMark helps partners optimize clinical trial design, discover novel biomarkers, and potentially rescue failed drug programs. The technology is particularly effective at handling small, high-dimensional datasets common in rare diseases and precision medicine. NetraMark operates as a technology partner for large pharmaceutical companies and biotech firms, aiming to reduce the high costs and failure rates associated with drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NetraAI.